EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
+6.38%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$514M
AUM Growth
+$514M
(+19%)
Cap. Flow
+$81.8M
Cap. Flow
% of AUM
15.92%
Top 10 Holdings %
Top 10 Hldgs %
68.1%
Holding
30
New
3
Increased
9
Reduced
4
Closed
3
Top Buys
| 1 |
Lantheus
LNTH
|
$23.5M |
| 2 |
Sarepta Therapeutics
SRPT
|
$19.1M |
| 3 |
Illumina
ILMN
|
$16.2M |
| 4 |
Guardant Health
GH
|
$12.4M |
| 5 |
Intuitive Surgical
ISRG
|
$8.91M |
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$14.8M |
| 2 |
Tandem Diabetes Care
TNDM
|
$6.7M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$3.8M |
| 4 |
10x Genomics
TXG
|
$1.79M |
| 5 |
Natera
NTRA
|
$1.67M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Illumina
ILMN
$15.4B
| $48.2M | 9.39% |
207,472
+69,558
| +50% | +$16.2M |
|
2
IQVIA
IQV
$31.3B
| $45M | 8.77% |
226,495
+22,400
| +11% | +$4.46M |
|
|
3
Natera
NTRA
$23.3B
| $43.6M | 8.48% |
784,894
-30,100
| -4% | -$1.67M |
|
|
4
Intuitive Surgical
ISRG
$168B
| $36.6M | 7.12% |
143,090
+34,860
| +32% | +$8.91M |
|
|
SGEN
5
DELISTED
Seagen Inc. Common Stock
SGEN
| $35.4M | 6.89% |
174,902
| – | – |
|
6
Icon
ICLR
$13.8B
| $33.3M | 6.48% |
155,900
+32,800
| +27% | +$7.01M |
|
7
United Therapeutics
UTHR
$18.4B
| $29.4M | 5.72% |
131,238
| – | – |
|
|
8
Alnylam Pharmaceuticals
ALNY
$58.8B
| $27.4M | 5.33% |
136,756
-18,960
| -12% | -$3.8M |
|
9
DexCom
DXCM
$29.3B
| $26.9M | 5.24% |
231,600
+12,600
| +6% | +$1.46M |
|
10
argenx
ARGX
$43B
| $24M | 4.67% |
64,400
+4,100
| +7% | +$1.53M |
|
11
Inspire Medical Systems
INSP
$2.78B
| $23.8M | 4.63% |
101,543
| – | – |
|
|
12
Lantheus
LNTH
$3.76B
| $23.5M | 4.58% |
+284,800
| New | +$23.5M |
|
13
Outset Medical
OM
$243M
| $22.1M | 4.3% |
1,200,385
-20,224
| -2% | -$372K |
|
|
14
Sarepta Therapeutics
SRPT
$1.78B
| $19.1M | 3.72% |
+138,640
| New | +$19.1M |
|
|
15
Tandem Diabetes Care
TNDM
$866M
| $17.3M | 3.36% |
425,525
-164,975
| -28% | -$6.7M |
|
|
16
Guardant Health
GH
$8.3B
| $14M | 2.72% |
596,561
+530,001
| +796% | +$12.4M |
|
17
Adaptive Biotechnologies
ADPT
$1.95B
| $10.7M | 2.09% |
1,214,860
+607,000
| +100% | +$5.36M |
|
18
Procept Biorobotics
PRCT
$2.21B
| $8.07M | 1.57% |
+284,218
| New | +$8.07M |
|
19
4D Molecular Therapeutics
FDMT
$288M
| $7.53M | 1.47% |
437,911
| – | – |
|
20
Agios Pharmaceuticals
AGIO
$2.27B
| $6.15M | 1.2% |
267,630
| – | – |
|
|
CANO
21
DELISTED
Cano Health, Inc.
CANO
| $3.9M | 0.76% |
4,290,901
+4,070,617
| +1,848% | +$3.7M |
|
22
American Well
AMWL
$108M
| $3.29M | 0.64% |
1,395,039
| – | – |
|
|
CMAX
23
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $1.91M | 0.37% |
714,755
| – | – |
|
|
OLK
24
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $901K | 0.18% |
40,000
| – | – |
|
25
Beam Therapeutics
BEAM
$1.65B
| $885K | 0.17% |
28,900
| – | – |
|